INMUNE BIO INC. (INMB) Net margin 2020–2025
INMUNE BIO INC. (INMB) net profit margin by fiscal year — reported net income divided by reported revenue.
-92000.0%FY2025 · since FY2020: -109990.9% → -92000.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -92000.0% | +208000.0 pp |
| FY2024 | -300000.0% | -280645.2 pp |
| FY2023 | -19354.8% | -12055.6 pp |
| FY2022 | -7299.2% | +9463.2 pp |
| FY2021 | -16762.4% | +93228.5 pp |
| FY2020 | -109990.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice